Schizophrenia Clinical Trials in Philadelphia

Showing 121-140 of 149 trials

Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone

NCT00535132

The purpose of this study is to evaluate medication satisfaction after at least 4 weeks of paliperidone ER (extended-release), an antipsychotic, treatment in patients with schizophrenia who were previously taking either 4 or 6 mg of risperidone daily by mouth, but who are not satisfied with their treatment.

Schizophrenia

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.201 participantsStarted Oct 2007

Cerritos, California, United States • Garden Grove, California, United States • Huntington Beach, California, United States +37 more locations

COMPLETEDPhase 2< 1 mile

Study Evaluating Vabicaserin in Subjects With Schizophrenia

NCT00563706

The primary purpose of this protocol is to establish the efficacy, safety, and tolerability of vabicaserin (SCA-136) using a once a day capsule in subjects with acute exacerbations of schizophrenia.

Schizophrenia

Pfizer199 participantsStarted Dec 2007

Little Rock, Arkansas, United States • Cerritos, California, United States • Escondido, California, United States +30 more locations

Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone

Study Evaluating Vabicaserin in Subjects With Schizophrenia

Schizophrenia Trials in Other Cities

Long-Acting Injectable Risperidone in the Treatment of Schizophrenia

A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents

Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic Patients

Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary Endpoint

A Long-Term, Open-Label, Study on Schizophrenia

CAFE Comparison of Atypicals in First Episode of Psychosis

Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With Schizophrenia

The Effects AZD8529 on Cognition and Negative Symptoms in Schizophrenics

Add On Treatment for Cognitive Deficits in Schizophrenia

Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

Safety and Cognitive Function Study of EVP-6124 in Patients With Schizophrenia

Effects of Cariprazine on Cardiac Repolarization in Patients With Schizophrenia

Measuring Smoking Behavior in People With Schizophrenia and Bipolar Disorder

Effects of Aripiprazole in Overweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective Disorder

Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects

28-30 Month Study Comparing Paliperidone Palmitate With Oral Risperidone for Treating Adults Diagnosed With Schizophrenia Within the Past 5 Years

A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children

Other Conditions in Philadelphia